Skip to main content
Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Real-Time Price · USD
19.76
+0.22 (1.13%)
At close: Nov 13, 2024, 4:00 PM
19.99
+0.23 (1.16%)
After-hours: Nov 13, 2024, 5:24 PM EST

Bausch + Lomb Revenue

Bausch + Lomb had revenue of $1.20B in the quarter ending September 30, 2024, with 18.77% growth. This brings the company's revenue in the last twelve months to $4.68B, up 18.01% year-over-year. In the year 2023, Bausch + Lomb had annual revenue of $4.15B with 10.03% growth.

Revenue (ttm)
$4.68B
Revenue Growth
+18.01%
P/S Ratio
1.47
Revenue / Employee
$352,180
Employees
13,300
Market Cap
6.96B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.15B378.00M10.03%
Dec 31, 20223.77B3.00M0.08%
Dec 31, 20213.77B353.00M10.35%
Dec 31, 20203.41B-366.00M-9.69%
Dec 31, 20193.78B113.00M3.08%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 7.81B
Elanco Animal Health 4.45B
RadNet 1.77B
Halozyme Therapeutics 947.36M
Legend Biotech 520.18M
Blueprint Medicines 434.42M
Cytokinetics 3.22M
Revenue Rankings

BLCO News

More News